Rivipansel

DB12778InvestigationalSmall molecule

Rivipansel has been used in trials studying the other, basic science, and treatment of Pain Crisis, Renal impairment, Anemia, Sickle Cell, Sickle Cell Disease, and Sickle Cell Disorders, among others.

Chemical structure of Rivipansel
Mechanism
Curator reviewed
Formula / weight
C58H74N6O31S3 · 1447.42 g/mol (avg)
Also known as
GMI-1070
Code names
PF-06460031

Resolves to

Structure
InChIKeyVXBNTHRZPJLRSS-PTCSXESPSA-NSMILES[H][C@@](CC1CCCCC1)(O[C@H]1[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]2C[C@@H](C[C@H](NC(=O)C3=CC(=O)NC(=O)N3)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)C(=O)NCCNC(=O)COCCOCC(=O)NC2=C3C(=CC(=C2)S(O)(=O)=O)C=C(C=C3S(O)(=O)=O)S(O)(=O)=O)[C@@H]1OC(=O)C1=CC=CC=C1)C(O)=O

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Rivipansel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account